The current earnings forecast score of Repare Therapeutics Inc is 7.00, ranking 312 out of 394 in the Biotechnology & Medical Research industry. The average price target is 3.00, with a high of 3.00 and a low of 3.00.
No Data
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Repare Therapeutics Inc's expected revenue for the next quarter?
Repare Therapeutics Inc's expected revenue is 2.50M.
What is Repare Therapeutics Inc's price target?
Analysts forecast that Repare Therapeutics Inc's price target is USD 3.00, with the highest forecast at USD 3.00 and the lowest forecast at USD 3.00.
How have Repare Therapeutics IncRPTX's recent earnings per share performed?
The market expectation was USD 0.08, while Repare Therapeutics IncRPTX's earnings per share (EPS) for the previous quarter was USD -0.39. EPS for the next quarter is expected at USD -0.42.